Clinical trial
Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic…
NCT00164073 · Bayside Health, Other · Unknown status
Key facts
| NCT number | NCT00164073 |
|---|---|
| Title | Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection |
| Official title | Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection |
| Lead sponsor | Bayside Health, Other |
| Collaborators | University of Adelaide |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Hepatitis C |
| Intervention type | Procedure |
| Interventions | Liver biopsy |
| Enrollment | 60 |
| Start date | Feb 1, 2004 |
| Completion | Feb 1, 2007 |
| First posted | Sep 14, 2005 |
| Last update posted | Aug 1, 2007 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: